Clinical Research Directory

Inclusion Criteria: 1. Adults aged 18 years or older. 2. Patients with a clinical indication for digital per-oral pancreatoscopy (POPS) as part of their diagnostic evaluation or preoperative assessment. 3. Patients with one or more of the following clinical indications: 3.1. Suspected or known main-duct or mixed-type IPMN. 3.2. Branch-duct IPMN with suspected communication with the main pancreatic duct and worrisome features or high-risk stigmata. 3.3. Indeterminate main pancreatic duct stricture, filling defect, or intraductal abnormality after cross-sectional imaging and/or EUS. 3.4. Need for preoperative assessment or mapping of IPMN extent. 4. Ability to undergo digital POPS according to the treating team's clinical assessment. 5. Ability to provide written informed consent. 6. Availability of an adequate reference-standard assessment, including histopathology when surgery is performed or tissue/cytologic assessment with clinical and imaging follow-up when surgery is not performed. 7. Willingness and ability to complete the required 6-month clinical/imaging follow-up when a surgical reference standard is not available. Exclusion Criteria: 1. Acute pancreatitis within 2 weeks before the planned pancreatoscopy. 2. Hemodynamic instability or clinical condition precluding safe pancreatoscopy. 3. ASA physical status IV or V when the treating team determines that the procedure cannot be safely performed. 4. Uncorrectable coagulopathy or other contraindication to pancreatoscopy and/or tissue sampling. 5. Pancreatic or gastrointestinal altered anatomy that prevents technically feasible digital POPS. 6. Evidence of unsafe pancreatic duct disruption or another anatomical or procedural condition that makes pancreatoscopy inappropriate. 7. Pregnancy. 8. Inability or unwillingness to provide informed consent. 9. Inability or unwillingness to complete the required follow-up when a non-surgical reference standard is necessary.